BiotechTube
Nucleus RadioPharma

Nucleus RadioPharma

Rochester, United States· Est.
nucleusrad.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $56M

Overview

Nucleus RadioPharma is a specialized CDMO addressing critical bottlenecks in the radiopharmaceutical supply chain. It offers comprehensive services including R&D, manufacturing, quality control, and supply chain logistics, all tailored for short-lived radioactive drugs. With a state-of-the-art facility in Rochester, MN, and planned expansions in Pennsylvania and Arizona, the company is scaling to become one of the world's largest purpose-built radiopharmaceutical CDMO networks. Its model is designed to help biotech and pharma companies rapidly commercialize novel targeted radiotherapies for cancer.

Oncology

Technology Platform

Integrated CDMO platform purpose-built for radiopharmaceuticals, featuring isotope-agnostic R&D and manufacturing, end-to-end supply chain logistics, and a strategically located network of facilities near major medical centers.

Funding History

1
Total raised:$56M
Series A$56M

Opportunities

The company is positioned to capitalize on the severe shortage of manufacturing and supply chain capacity for the rapidly growing field of targeted radiotherapies.
Its strategic expansion creates a first-mover advantage as a scaled, pure-play radiopharma CDMO, enabling it to capture significant market share from both emerging biotechs and large pharma partners seeking reliable outsourcing.

Risk Factors

Key risks include execution risk associated with its aggressive multi-site expansion plan, dependency on the clinical success of its clients' drug candidates, and the inherent operational and regulatory risks of handling short-lived radioactive materials across a complex supply chain.

Competitive Landscape

Nucleus competes with in-house capabilities of large radiopharma companies (e.g., Novartis, Bayer) and a limited number of specialized CDMOs like Curium Pharma, NorthStar Medical Radioisotopes, and ITM Isotope Technologies Munich. Its differentiation lies in its dedicated, large-scale, US-based network and full-service, isotope-agnostic model designed specifically for the speed required in this field.

More companies in Radiopharmaceuticals →More companies in United States →